Hysterectomy for cervical intraepithelial neoplasia: A retrospective observational multi-institutional study.

cervical intraepithelial neoplasia conization human papillomavirus hysterectomy vaginal cancer vaginal intraepithelial neoplasia

Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
Dec 2022
Historique:
revised: 04 04 2022
received: 16 01 2022
accepted: 21 04 2022
pubmed: 28 4 2022
medline: 16 11 2022
entrez: 27 4 2022
Statut: ppublish

Résumé

To analyze the clinical management, the outcomes, and the trend in hysterectomy rates (HR) in patients who underwent this procedure for cervical intraepithelial neoplasia (CIN). Multicentric retrospective observational study conducted on 242 patients who underwent hysterectomy for CIN between 2010 and 2020 in nine Italian institutions. Hysterectomy for invasive or micro-invasive neoplasia, sub-total hysterectomy, or trachelectomy were excluded. A significant increase in the trend of HR for CIN was recorded (P = 0.002, r = 0.81; C.I. 95%: 0.415-0.949); HR increased from 0.46% in the year 2010 to 3.32% in 2020. The mortality rate was 0.4%, and 5% had operative complications. On definitive histopathology examination, a CIN of any grade was recorded in 71.5% of cases, and an occult invasive cancer in 1.24%. No pathology or CIN1 was found in 26.8% of cases, suggesting over treatment. During follow-up, a vaginal lesion was recorded in 5% of cases. A significant increase in the number of hysterectomies performed for CIN in the last 10 years was recorded. Hysterectomy for CIN can lead to complications, risk of the onset of vaginal lesions, and risk of overtreatment, and remains, in the first instance, an unacceptable treatment, to be proposed only after adequate counseling.

Identifiants

pubmed: 35474511
doi: 10.1002/ijgo.14233
pmc: PMC9790541
doi:

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

679-688

Informations de copyright

© 2022 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

Références

Cytopathology. 2009 Feb;20(1):5-16
pubmed: 19133067
Cochrane Database Syst Rev. 2013 Dec 04;(12):CD001318
pubmed: 24302546
Epidemiol Prev. 2016 Sep-Oct;40(5):381
pubmed: 27764935
BMJ. 2014 Jan 14;348:f7361
pubmed: 24423603
Br J Obstet Gynaecol. 1992 Nov;99(11):907-10
pubmed: 1450141
Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4747-4754
pubmed: 29164591
J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S1-S27
pubmed: 23519301
BJOG. 2020 Sep;127(10):1269-1279
pubmed: 32145133
Acta Obstet Gynecol Scand. 2019 Jun;98(6):737-746
pubmed: 30687935
Int J Gynaecol Obstet. 2022 Dec;159(3):679-688
pubmed: 35474511
J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S78-84
pubmed: 23519309
Int J Gynaecol Obstet. 2020 Jun;149(3):269-272
pubmed: 32270477
Lancet Oncol. 2008 May;9(5):425-34
pubmed: 18407790
Ginecol Obstet Mex. 1999 Sep;67:415-8
pubmed: 10544536
BMJ. 2014 Jan 14;348:f7700
pubmed: 24423750
J Low Genit Tract Dis. 2003 Jan;7(1):32-5
pubmed: 17051042
Curr Probl Cancer. 2021 Jun;45(3):100687
pubmed: 33309077
Int J Gynecol Cancer. 2020 Aug;30(8):1097-1100
pubmed: 32487685
Am J Obstet Gynecol. 2019 Jul;221(1):39.e1-39.e14
pubmed: 30853364
Int J Gynecol Cancer. 2021 Mar;31(3):447-451
pubmed: 33649012
Radiother Oncol. 2018 Jun;127(3):404-416
pubmed: 29728273
Am J Obstet Gynecol. 2008 Aug;199(2):113.e1-5
pubmed: 18456229
Am J Obstet Gynecol. 2003 Jul;189(1):295-304
pubmed: 12861176
BJOG. 2020 Mar;127(4):448-454
pubmed: 31769577
J Obstet Gynaecol. 2006 Feb;26(2):157-8
pubmed: 16483977
J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S36-42
pubmed: 23519303
Gynecol Surg. 2015;12(3):165-177
pubmed: 26283890
Eur J Gynaecol Oncol. 1997;18(3):188-91
pubmed: 9174833
Obstet Gynecol. 2009 Jan;113(1):18-25
pubmed: 19104355
Br J Obstet Gynaecol. 1990 Jan;97(1):58-61
pubmed: 2306428

Auteurs

Andrea Ciavattini (A)

Obstetrics and Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy.

Jacopo Di Giuseppe (J)

Obstetrics and Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy.

Chiara Marconi (C)

Obstetrics and Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy.

Luca Giannella (L)

Obstetrics and Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy.

Giovanni Delli Carpini (G)

Obstetrics and Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy.

Michela Paolucci (M)

Obstetrics and Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy.

Mariasole Fichera (M)

Obstetrics and Gynecologic Section, Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy.

Rosa Pasqualina De Vincenzo (RP)

Gynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy.

Giovanni Scambia (G)

Gynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy.

Maria Teresa Evangelista (MT)

Gynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

Giorgio Bogani (G)

Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Francesca Bertolina (F)

Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Francesco Raspagliesi (F)

Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Barbara Gardella (B)

Department of Obstetrics and Gynecology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Foundation Policlinico San Matteo and University of Pavia, Pavia, Italy.

Arsenio Spinillo (A)

Department of Obstetrics and Gynecology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Foundation Policlinico San Matteo and University of Pavia, Pavia, Italy.

Mattia Dominoni (M)

Department of Obstetrics and Gynecology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Foundation Policlinico San Matteo and University of Pavia, Pavia, Italy.

Ermelinda Monti (E)

Gynecology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Carlo Antonio Liverani (CA)

Gynecology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Paolo Vercellini (P)

Gynecology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Maria Iorio (M)

Gynecology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Domenico Vitobello (D)

IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Rosalba Portuesi (R)

IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Gianluigi Bresciani (G)

IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Massimo Origoni (M)

Vita Salute San Raffaele University School of Medicine - Department of Gynecology & Obstetrics, Milan, Italy.

Francesco Cantatore (F)

Vita Salute San Raffaele University School of Medicine - Department of Gynecology & Obstetrics, Milan, Italy.

Antonio Maurizio Pellegri (AM)

Vita Salute San Raffaele University School of Medicine - Department of Gynecology & Obstetrics, Milan, Italy.

Lorenzo Moriconi (L)

Obstetrics and Gynecologic Unit, A.S.U.R, Benedetto del Tronto (AP), Italy.

Matteo Serri (M)

Obstetrics and Gynecologic Unit, A.S.U.R, Benedetto del Tronto (AP), Italy.

Andrea Chiari (A)

Obstetrics and Gynecologic Unit, A.S.U.R, Benedetto del Tronto (AP), Italy.

Francesco Sopracordevole (F)

Gynecological Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Maggiorino Barbero (M)

Department of Obstetrics and Gynecology, Asti Community Hospital, Asti, Italy.

Fabio Parazzini (F)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano Facoltà di Medicina e Chirurgia, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH